PI3K/Akt and NF-κB activation following intravitreal administration of 17β-estradiol: Neuroprotection of the rat retina from light-induced apoptosis

Neuroscience

Volumn 228, Issue , 2013, Pages 1-12

  Mo, M S ^a   Li, H B ^a   Wang, B Y ^a   Wang, S L ^a   Zhu, Z L ^a   Yu, X R ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

17 estradiol; Apoptosis; Light damage; NF B; Oxidative stress; PI3K Akt

Indexed keywords

CASPASE 3; DEOXYURIDEN TRIPHOSPHATE; EOSIN; ESTRADIOL; HEMATOXYLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTRORETINOGRAM; ENZYME ACTIVATION; ENZYME ASSAY; FEMALE; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LIGHT DAMAGE; MOLECULAR DYNAMICS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RAT; RETINA NERVE CELL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CHROMONES; ESTRADIOL; FEMALE; INTRAVITREAL INJECTIONS; MORPHOLINES; NEUROPROTECTIVE AGENTS; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PHOTIC STIMULATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RETINA;

EID: 84868545451     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.10.002     Document Type: Article

References (46)

1. Bertram K.M., Baglole C.J., Phipps R.P., Libby R.T. Molecular regulation of cigarette smoke induced-oxidative stress in human retinal pigment epithelial cells: implications for age-related macular degeneration. Am J Physiol Cell Physiol 2009, 297:1200-1210.
2. Carroll J., Rosario E., Chang L., Stanczyk F., Oddo S., LaFerla F., Pike C. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3×Tg-AD mice. J Neurosci 2007, 27:13357.
3. Dentchev T., Yao Y., Praticó D., Dunaief J.L. Isoprostane F2α-VI, a new marker of oxidative stress, increases following light damage to the mouse retina. Mol Vis 2007, 13:190.
4. Deschenes M., Descovich D., Moreau M., Granger L., Kuchel G., Mikkola T., Fick G., Chemtob S., Vaucher E., Lesk M. Postmenopausal hormone therapy increases retinal blood flow and protects the retinal nerve fiber layer. Invest Ophthalmol Vis Sci 2009, 51:2587-2600.
5. Dunaief J.L., Dentchev T., Ying G.S., Milam A.H. The role of apoptosis in age-related macular degeneration. Arch Ophthalmol 2002, 120:1435-1442.
6. Dziennis S., Jia T., Rønnekleiv O.K., Hurn P.D., Alkayed N.J. Role of signal transducer and activator of transcription-3 in estradiol-mediated neuroprotection. J Neurosci 2007, 27:7268-7274.
7. Edwards D.R.V., Gallins P., Polk M., Ayala-Haedo J., Schwartz S.G., Kovach J.L., Spencer K., Wang G.F., Agarwal A., Postel E.A., Haines J.L., Pericak-Vance M., Scott W.K. Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms. Invest Ophthalmol Vis Sci 2010, 51:1873-1879.
8. Fraser-Bell S., Wu J., Klein R., Azen S.P., Hooper C., Foong A.W., Varma R. Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino eye study. Am J Ophthalmol 2007, 145:308-316.
9. Gollapudi L., Oblinger M.M. Stable transfection of PC12 cells with estrogen receptor (ERα): protective effects of estrogen on cell survival after serum deprivation. J Neurosci Res 1999, 56:99-108.
10. Green P.G., Dahlqvist S.R., Isenberg W.M., Strausbaugh H.J., Miao F.J.P., Levine J.D. Sex steroid regulation of the inflammatory response: sympathoadrenal dependence in the female rat. J Neurosci 1999, 19:4082-4089.
11. Henderson V. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience 2006, 138:1031-1039.
12. Hilton G.D., Nunez J.L., Bambrick L., Thompson S.M., McCarthy M.M. Glutamate-mediated excitotoxicity in neonatal hippocampal neurons is mediated by mGluR-induced release of Ca++ from intracellular stores and is prevented by estradiol. Eur J Neurosci 2006, 24:3008-3016.
13. Ihekwaba A., Broomhead D., Grimley R., Benson N., Kell D. Sensitivity analysis of parameters controlling oscillatory signalling in the NF-kB pathway: the roles of IKK and IkBa. Syst Biol 2004, 1:93.
14. Izumi Y., Ishikawa M., Benz A.M., Izumi M., Zorumski C.F., Thio L.L. Acute vigabatrin retinotoxicity in albino rats depends on light but not GABA. Epilepsia 2004, 45:1043-1048.
15. Joly S., Pernet V., Chemtob S., Di Polo A., Lachapelle P. Neuroprotection in the juvenile rat model of light-induced retinopathy: evidence suggesting a role for FGF-2 and CNTF. Invest Ophthalmol Vis Sci 2007, 48:2311-2320.
16. Joly S., Pernet V., Dorfman A.L., Chemtob S., Lachapelle P. Light-induced retinopathy: comparing adult and juvenile rats. Invest Ophthalmol Vis Sci 2006, 47:3202-3212.
17. Káldi I., Dittmar M., Pierce P., Anderson R. L-NAME protects against acute light damage in albino rats, but not against retinal degeneration in P23H and S334ter transgenic rats. Exp Eye Res 2003, 76:453-461.
18. Kaja S., Yang S., Wei J., Fujitani K., Liu R., Brun-Zinkernagel A., Simpkins J., Inokuchi K., Koulen P. Estrogen protects the inner retina from apoptosis and ischemia-induced loss of Vesl-1L/Homer 1c immunoreactive synaptic connections. Invest Ophthalmol Vis Sci 2003, 44:3155.
19. Kim I.T., Park H.Y.L., Choi J.S., Joo C.K. Anti-angiogenic effect of KR-31831 on corneal and choroidal neovascularization in rat models. Invest Ophthalmol Vis Sci. 2012, 53:3111-3119.
20. Kunchithapautham K., Coughlin B., Lemasters J.J., Rohrer B. Differential effects of rapamycin on rods and cones during light-induced stress in albino mice. Invest Ophthalmol Vis Sci 2011, 52:2967.
21. Kunchithapautham K., Rohrer B. Apoptosis and autophagy in photoreceptors exposed to oxidative stress. Autophagy 2007, 3:433.
22. Liu S., Zhang N., Guo Y., Zhao R., Shi T., Feng S., Wang S., Yang Q., Li X., Wu Y. G-protein-coupled receptor 30 mediates rapid neuroprotective effects of estrogen via depression of NR2B-containing NMDA receptors. J Neurosci 2012, 32:4887-4900.
23. Mémet S. NF-kappaB functions in the nervous system: from development to disease. Biochem Pharmacol 2006, 72:1180-1195.
24. Mannella P., Brinton R. Estrogen receptor protein interaction with phosphatidylinositol 3-kinase leads to activation of phosphorylated Akt and extracellular signal-regulated kinase 1/2 in the same population of cortical neurons: a unified mechanism of estrogen action. J Neurosci 2006, 26:9439.
25. Marc R., Jones B., Watt C., Vazquez-Chona F., Vaughan D., Organisciak D. Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration. Mol Vis 2008, 14:782.
26. Munaut C., Lambert V., Noël A., Frankenne F., Deprez M., Foidart J.M., Rakic J.M. Presence of oestrogen receptor type β in human retina. Br J Ophthalmol 2001, 85:877-882.
27. Ogueta S.B., Schwartz S.D., Yamashita C.K., Farber D.B. Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci 1999, 40:1906-1911.
28. Rogers Rachel, Ouellet Gregory, Brown Caitlin, Moyer Ben, Rasoulpour Teresa, Hixon Mary Cross-talk between the Akt and NF-κB signaling pathways inhibits MEHP-induced germ cell apoptosis 2008, Oxford University Press, Oxford, Royaume-Uni.
29. Sarkaki A., Badavi M., Hoseiny N., Gharibnaseri M., Rahim F. Postmenopausal effects of intrastriatal estrogen on catalepsy and pallidal electroencephalogram in an animal model of Parkinson's disease. Neuroscience 2008, 154:940-945.
30. Shen J., Yang X., Dong A., Petters R., Peng Y., Wong F., Campochiaro P. Oxidative damage is a potential cause of cone cell death in retinitis pigmentosa. J Cell Physiol 2005, 203:457-464.
31. Singer C.A., Figueroa-Masot X.A., Batchelor R.H., Dorsa D.M. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 1999, 19:2455-2463.
32. Sparrow J.R., Zhou J., Ben-Shabat S., Vollmer H., Itagaki Y., Nakanishi K. Involvement of oxidative mechanisms in blue-light-induced damage to A2E-laden RPE. Invest Ophthalmol Vis Sci 2002, 43:1222.
33. Stirone C., Duckles S., Krause D., Procaccio V. Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol Pharmacol 2005, 68:959.
34. Strehlow K., Rotter S., Wassmann S., Adam O., Grohe C., Laufs K., Bohm M., Nickenig G. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 2003, 93:170.
35. Sun M.H., Pang J.H., Chen S.L., Kuo P.C., Chen K.J., Kao L.Y., Wu J.Y., Lin K.K., Tsao Y.P. Photoreceptor protection against light damage by AAV-mediated overexpression of heme oxygenase-1. Invest Ophthalmol Vis Sci 2007, 48:5699-5707.
36. Szego E., Barabas K., Balog J., Szilagyi N., Korach K., Juhasz G., Abraham I. Estrogen induces estrogen receptor α-dependent cAMP response element-binding protein phosphorylation via mitogen activated protein kinase pathway in basal forebrain cholinergic neurons in vivo. J Neurosci 2006, 26:4104.
37. Tanito M., Masutani H., Kim Y., Nishikawa M., Ohira A., Yodoi J. Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice. Invest Ophthalmol Vis Sci 2005, 46:979.
38. Taylor H.R., Munoz B., West S., Bressler N.M., Bressler S.B., Rosenthal F.S. Visible light and risk of age-related macular degeneration. Trans Am Ophthalmol Soc 1990, 88:163.
39. Vegeto E., Benedusi V., Maggi A. Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Front Neuroendocrin 2008, 29:507-519.
40. Wang Q., Tompkins K., Simonyi A., Korthuis R., Sun A., Sun G. Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus. Brain Res 2006, 1090:182-189.
41. Wen Y., Yang S., Liu R., Perez E., Yi K., Koulen P., Simpkins J. Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia. Brain Res 2004, 1008:147-154.
42. Weymouth A.E., Vingrys A.J. Rodent electroretinography: methods for extraction and interpretation of rod and cone responses. Prog Retin Eye Res 2008, 27:1-44.
43. 2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: a potential initiation mechanism for estrogen-induced neuroprotection. Neuroscience 2005, 135:59-72.
44. Xu K., Xu Y., Brown-Jermyn D., Chen J., Ascherio A., Dluzen D., Schwarzschild M. Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease. J Neurosci 2006, 26:535.
45. Yu X., Rajala R., McGinnis J., Li F., Anderson R., Yan X., Li S., Elias R., Knapp R., Zhou X. Involvement of insulin/phosphoinositide 3-kinase/Akt signal pathway in 17β-estradiol-mediated neuroprotection. J Biol Chem 2004, 279:13086.
46. Zhang Q., Raz L., Wang R., Han D., De Sevilla L., Yang F., Vadlamudi R., Brann D. Estrogen attenuates ischemic oxidative damage via an estrogen receptor α-mediated inhibition of NADPH oxidase activation. J Neurosci 2009, 29:13823.